Increased Risk for Venous Thromboembolism in Patients Receiving Anticoagulant Therapy for Pulmonary Embolism - Hematology Advisor

Increased Risk for Venous Thromboembolism in Patients Receiving Anticoagulant Therapy for Pulmonary Embolism  Hematology Advisor

A study recently published in the Journal of Clinical Oncology reported that patients with cancer who are diagnosed with incidental pulmonary embolism (PE) ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more